Bacteriophage-encoding cytolethal distending toxin type V gene induced from nonclinical Escherichia coli isolates

Infection and Immunity

Volumn 79, Issue 8, 2011, Pages 3262-3272

  Allué Guardia, Anna ^a   García Aljaro, Cristina ^a   Muniesa, Maite ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; CYTOLETHAL DISTENDING TOXIN V; MITOMYCIN C; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATE; CONTROLLED STUDY; DENSITY; GENE DOSAGE; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; HELA CELL; LYSOGENIZATION; MOLECULAR CLONING; MORPHOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SHIGELLA SONNEI; SUPERNATANT; WATER SAMPLING; WILD TYPE;

BACTERIAL TOXINS; COLIPHAGES; DNA, VIRAL; HELA CELLS; HUMANS; LYSOGENY; MITOMYCIN; MOLECULAR SEQUENCE DATA; PROPHAGES; SEQUENCE ANALYSIS, DNA; SHIGA-TOXIGENIC ESCHERICHIA COLI; SHIGELLA SONNEI; SIPHOVIRIDAE; VIRAL PROTEINS; VIRUS ACTIVATION;

EID: 79961110942     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05071-11     Document Type: Article

References (43)

1. Asakura, M., et al. 2007. An inducible lambdoid prophage encoding cytolethal distending toxin (Cdt-I) and a type III effector protein in enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 104:14483-14488.
2. Baggi, F., A. Demarta, and R. Peduzzi. 2001. Persistence of viral pathogens and bacteriophages during sewage treatment: lack of correlation with indicator bacteria. Res. Microbiol. 152:743-751.
3. Bielaszewska, M., et al. 2009. Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates. J. Clin. Microbiol. 47:2061-2066.
4. Bielaszewska, M., et al. 2004. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 72:1812-1816.
5. Boesze-Battaglia, K., et al. 2006. Cholesterol-rich membrane microdomains mediate cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal-distending toxin. Cell Microbiol. 8:823-836.
6. Canchaya, C., C. Proux, G. Fournous, A. A. Bruttin, and H. Brüssow. 2003. Prophage genomics. Microbiol. Mol. Biol. 67:238-276.
7. Cangelosi, G. A., N. E. Freitag, and M. R. Buckley. 2004. From outside to inside: environmental microorganisms as human pathogens. American Academy of Microbiology Report. ASM, Washington, DC.
8. Canton, R. 2009. Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting. Clin. Microbiol. Infect. 1:20-25.
9. Clark, C. G., S. T. Johnson, R. H. Easy, J. L. Campbell, and F. G. Rodgers. 2002. PCR for detection of cdt-III and the relative frequencies of cytolethal distending toxin variant-producing Escherichia coli isolates from humans and cattle. J. Clin. Microbiol. 40:2671-2674.
10. Fogg, P. C., et al. 2007. Identification of multiple integration sites for Stxphage Phi24B in the Escherichia coli genome, description of a novel integrase and evidence for a functional anti-repressor. Microbiology 153:4098-4110.
11. Franki, R. I. B., C. M. Fauquet, D. L. Knudson, and F. Brown. 1991. Classification and nomenclature of viruses. Fifth report of the International Committee on Taxonomy of Viruses. Arch. Virol., suppl. 2. Springer-Verlag, Vienna, Austria.
12. Friedrich, A. W., et al. 2006. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J. Clin. Microbiol. 44:1844-1846.
13. Garcia-Aljaro, C., et al. 2005. Characterization of Shiga toxin-producing Escherichia coli isolated from aquatic environments. FEMS Microbiol. Lett. 246:55-65.
14. García-Aljaro, C., M. Muniesa, J. Jofre, and A. R. Blanch. 2004. Prevalence of the stx2 gene in coliform populations from aquatic environments. Appl. Environ. Microbiol. 70:3535-3540.
15. Ge, Z., D. B. Schauer, and J. G. Fox. 2008. In vivo virulence properties of bacterial cytolethal-distending toxin. Cell Microbiol. 10:1599-1607.
16. Guinée, P. A. M., W. H. Jansen, T. Wadström, and R. Sellwood. 1981. Escherichia coli associated with neonatal diarrhea in piglets and calves. Curr. Top. Vet. Anim. Sci. 13:126-162.
17. Haghjoo, E., and J. E. Galan. 2004. Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterialinternalization pathway. Proc. Natl. Acad. Sci. U. S. A. 101:4614-4619.
18. Imamovic, L., E. Ballesté, J. Jofre, and M. Muniesa. 2010. Shiga-toxin converting bacteriophages in wastewater and fecal samples quantified by qPCR. Appl. Environ. Microbiol. 76:5693-5701.
19. Janka, A., et al. 2003. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H-and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71:3634-3638.
20. Jerse, A. E., J. Yu, B. D. Tall, and J. B. Kaper. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl. Acad. Sci. U. S. A. 87:7839-7843.
21. Johnson, W. M., and H. Lior. 1987. Response of Chinese hamster ovary cells to a cytolethal distending toxin (CDT) of Escherichia coli and possible misinterpretation as heat-labile (LT) enterotoxin. FEMS Microbiol. Lett. 43: 19-23.
22. Karch, H., P. I. Tarr, and M. Bielaszewska. 2005. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295:405-418.
23. Kimmitt, P. T., C. R. Harwood, and M. R. Barer. 2000. Toxin gene expression by Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg. Infect. Dis. 6:458-465.
24. Liu, Y., and E. Haggard-Ljungquist. 1994. Studies of bacteriophage P2 DNA replication: localization of the cleavage site of the A protein. Nucleic Acids Res. 22:5204-5210.
25. Livny, J., and D. I. Friedman. 2004. Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system. Mol. Microbiol. 51:1691-1704.
26. Muniesa, M., et al. 2004. Bacteriophages and diffusion of beta-lactamase genes. Emerg. Infect. Dis. 10:1134-1137.
27. Muniesa, M., and J. Jofre. 1998. Abundance in sewage of bacteriophages that infect Escherichia coli O157:H7 and that carry the Shiga toxin 2 gene. Appl. Environ. Microbiol. 64:2443-2448.
28. Muniesa, M., et al. 2004. Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle. Microbiology 150:2959-2971.
29. Muniesa, M., J. Recktenwald, M. Bielaszewska, H. Karch, and H. Schmidt. 2000. Characterization of a Shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin. Infect. Immun. 68:4850-4855.
30. Ohara, M., E. Oswald, and M. Sugai. 2004. Cytolethal distending toxin: a bacterial bullet targeted to nucleus. J. Biochem. 136:409-413.
31. Pickett, C. L., and C. A. Whitehouse. 1999. The cytolethal distending toxin family. Trends Microbiol. 7:292-297.
32. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
33. Serra-Moreno, R., J. Jofre, and M. Muniesa. 2007. Insertion site occupancy by stx2 bacteriophages depends on the locus availability of the host strain chromosome. J. Bacteriol. 189:6645-6654.
34. Serra-Moreno, R., J. Jofre, and M. Muniesa. 2008. The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin J. Bacteriol. 190:4722-4735.
35. Sinton, L. W., R. K. Finley, and P. A. Lynch. 1999. Sunlight inactivation of fecal bacteriophages and bacteria in sewage-polluted seawater. Appl. Environ. Microbiol. 65:3605-3613.
36. Smith, J. L., and D. O. Bayles. 2006. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit. Rev. Microbiol. 32:227-248.
37. Tanji, Y., et al. 2003. Seasonal change and fate of coliphages infected to Escherichia coli O157:H7 in a waste water treatment plant. Water Res. 37:1136-1142.
38. Thelestam, M., and T. Frisan. 2004. Cytolethal distending toxins. Rev. Physiol. Biochem. Pharmacol. 152:111-133.
39. Tóth, I., F. Hérault, L. Beutin, and E. Oswald. 2003. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV). J. Clin. Microbiol. 41:4285-4291.
40. Tóth, I., et al. 2009. Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect. Immun. 77:492-500.
41. Waldor, M. K., D. I. Friedman, and S. L. Adhya. 2005. Phages: their role in bacterial pathogenesis and biotechnology. ASM Press, Washington, DC.
42. Whitehouse, C. A., et al. 1998. Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block. Infect. Immun. 66:1934-1940.
43. Zhang, X., et al. 2000. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181:664-670.